PAM
FATE icon

Panagora Asset Management’s Fate Therapeutics FATE Stock Holding History

Panagora Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-356,740
Closed -$1.33M – 1219
2023
Q4 		$1.33M Sell
356,740
-69,845
-16% -$165K 0.01% 709
2023
Q3 		$904K Buy
426,585
+107,098
+34% +$355K 0.01% 808
2023
Q2 		$1.52M Sell
319,487
-5,874
-2% -$32.4K 0.01% 644
2023
Q1 		$1.85M Buy
325,361
+5,041
+2% +$30.4K 0.01% 597
2022
Q4 		$3.23M Buy
320,320
+22,042
+7% +$414K 0.02% 481
2022
Q3 		$6.68M Sell
298,278
-2,374
-0.8% -$68.6K 0.05% 301
2022
Q2 		$7.45M Buy
300,652
+25,207
+9% +$695K 0.05% 301
2022
Q1 		$10.7M Buy
275,445
+616
+0.2% +$23.9K 0.06% 278
2021
Q4 		$16.1M Buy
274,829
+9,456
+4% +$536K 0.09% 217
2021
Q3 		$15.7M Buy
265,373
+33,473
+14% +$2.63M 0.08% 224
2021
Q2 		$20.1M Buy
231,900
+69,304
+43% +$5.58M 0.11% 193
2021
Q1 		$13.4M Buy
+162,596
New +$15.6M 0.08% 245
2018
Q3 		– Sell
-6,275
Closed -$71K – 2426
2018
Q2 		$71K Sell
6,275
-4,964
-44% -$54.7K ﹤0.01% 1958
2018
Q1 		$110K Sell
11,239
-12,224
-52% -$117K ﹤0.01% 1832
2017
Q4 		$143K Sell
23,463
-32
-0.1% -$143 ﹤0.01% 1775
2017
Q3 		$93K Sell
23,495
-6,015
-20% -$20.5K ﹤0.01% 1906
2017
Q2 		$96K Hold
29,510
– – ﹤0.01% 1886
2017
Q1 		$134K Hold
29,510
– – ﹤0.01% 1778
2016
Q4 		$74K Hold
29,510
– – ﹤0.01% 2019
2016
Q3 		$92K Buy
+29,510
New +$71.6K ﹤0.01% 1987

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Panagora Asset Management's FATE Position: Q1 2024 in Review

Panagora Asset Management sold out of Fate Therapeutics (FATE) in Q1 2024, closing a stake of 356,740 shares — an estimated $1.33M sold.

Panagora Asset Management first reported a position in FATE in Q3 2016 and held it in 20 quarters. The position peaked at $20.1M in Q2 2021. 167 funds tracked by Wall St. Rank hold FATE as of Q1 2024.

  • Panagora Asset Management reported no remaining Fate Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Panagora Asset Management sold 356,740 Fate Therapeutics shares in Q1 2024, an estimated $1.33M.
  • Panagora Asset Management first reported a position in Fate Therapeutics in Q3 2016 and held it in 20 quarters.
  • Panagora Asset Management's Fate Therapeutics position peaked at $20.1M in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2024.

Based on Panagora Asset Management's 13F filing for Q1 2024, filed 7 May 2024.